Clinical trial
Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung…
NCT00024076 · Jonsson Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00024076 |
|---|---|
| Title | Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer |
| Official title | Radiofrequency Ablation of Pulmonary Malignancy |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer, Malignant Mesothelioma, Metastatic Cancer, Thymoma and Thymic Carcinoma |
| Intervention type | Procedure |
| Interventions | radiofrequency ablation |
| Enrollment | 30 |
| Start date | May 1, 2000 |
| Primary completion | Dec 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 3, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: